InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（9 笔）
内部人交易记录
高级管理人员已披露买入
0
已披露卖出
9
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Browse the complete record of transactions filed by Carter Percy H., Directeur Scientifique. Insider active across 1 company, notably Blueprint Medicines Corp. Aggregated, 16 filings have been logged. Split: 0 buy · 9 sells. Total volume traded: €1.5m. Activity tracked since 1 June 2021. The latest transaction was disclosed on 3 July 2025 (Cession). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Carter Percy H.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报16 总计
21,353 股Common StockSEC:0001104659-25-069388:0
1,051 股@ US$128.257.8% 占其流量Common StockSEC:0001415889-25-019506:0
241 股@ US$127.881.8% 占其流量Common StockSEC:0001415889-25-015767:0
3,530 股@ US$88.8020.0% 占其流量Common StockSEC:0001415889-25-007375:0
11,000 股0Common StockSEC:0001415889-25-006604:0
7,500 股0Common StockSEC:0001415889-24-019391:0
4,000 股@ US$105.1326.2% 占其流量Common StockSEC:0001415889-24-015943:0
2,436 股@ US$106.4316.1% 占其流量Common StockSEC:0001415889-24-015540:0
2,286 股@ US$90.6912.9% 占其流量Common StockSEC:0001415889-24-007552:0
12,500 股0Common StockSEC:0001415889-24-007009:0
2,307 股@ US$52.067.6% 占其流量Common StockSEC:0001415889-23-009403:0
736 股@ US$45.722.1% 占其流量Common StockSEC:0001415889-23-004560:0
12,500 股0Common StockSEC:0001415889-23-004266:0
1,908 股@ US$59.76100.0% 占其流量Common StockSEC:0001415889-22-006308:0
8,750 股0Common StockSEC:0001415889-22-002441:0
21,843 股0Common StockSEC:0001179110-21-006329:0
16 条申报中的 16 条
About Carter Percy H.
Carter Percy H. is Directeur Scientifique and Chief Scientific Officer at Blueprint Medicines Corp, listed on XNAS. He has 16 filings in total, and across the 16 recent filings we hold, from 2021-06-03 to 2025-07-21, the activity consists only of sales, for sell volume of EUR 1501588.
